Trial NCT04341584
Publication CORIMUNO-19 Collaborative group, Lancet Respir Med, 2021
Primary outcome on the report: The proportion of patients who had died or needed non-invasive or mechanical ventilation by day 4 (ie, a score of >5 points on the WHO-CPS); and Survival with no need for mechanical or non-invasive ventilation (including high- flow oxygen) at day 14.